Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis.

Briefings in bioinformatics - 23 May 2024

Koopman Jacob J E, Buhler Katherine A, Choi May Y

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Dermatomyositis
Share to Immunodeficiency and Autoimmune Disorders
Share to Inflammatory Myopathies and Dermatomyositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-Induced Helicase, IFIH1

Share to Machine Learning

Share to Phenotype

Share to Skin Diseases and Diabetes

Source

Open in PubMed Open full text

Identifiers

PMID: 38920344
DOI: 10.1093/bib/bbae303
PMCID: PMC11200185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis.PMID 38920344Read ↗

Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.Semantic proximity Read ↗

Site-level cutaneous phenotyping framework for anti-MDA5-positive dermatomyositis: exploratory associations with systemic immune reference markers.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing.Semantic proximity Read ↗

Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity Read ↗

Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.Semantic proximity Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Clinical Features and a Nomogram for Predicting Infection in Anti-MDA5 Antibody-Positive Dermatomyositis: A Single-Center Retrospective StudySemantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

Clinical phenotype and prognostic determinants of spontaneous pneumomediastinum in anti-MDA5 antibody-positive dermatomyositis.Semantic proximity Read ↗

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicrySemantic proximity Read ↗

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.